MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
IGC — IGC Pharma, Inc.
NYSE AmericanIGC Pharma, Inc.
$0.27
+0.00(+1.81%)
- O
- 0.28
- H
- 0.28
- L
- 0.27
- V
- 601.38K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About IGC
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 13, 2006
Employees70
Stock ExchangeNYSE American
Ticker SymbolIGC
Websitehttps://www.igcinc.us
Key Financial Statistics
| Market Cap | $28.42M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.24 - $0.45 |
| 52-Week Avg Volume | 779.1K |
| VWAP | $0.27 |
| Transactions | 1,311 |
| Total Recorded Bars | 5,121 days |